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The replication of nonsegmented minus-strand RNA genomes, like that of Sendai paramyxovirus (SeV), are controlled by
the short leader regions present at each end of the linear genomes and antigenomes; the left and right promoters (PL and
PR), respectively. Wild-type SeV is highly cytopathic in cell culture, because it induces programmed cell death (PCD). We have
found that a recombinant SeV (rSeVGP42), in which the first 42 nt of le1 sequences at PL were replaced with the equivalent
sequences of PR, and which produces infectious virus in amounts comparable to wild type, does not kill cells. Further, the
increasing replacement of the terminal le1 sequences at PL with le2 sequences led to a decreasing fraction of infected cells
being apoptotic. This property (PCD2), moreover, is dominant in cells co-infected with SeVwt and rSeVGP42, and the mutant
virus therefore appears to have gained a function which prevents PCD induced by SeVwt. Even though this virus has not been
selected for naturally, it excludes SeVwt during co-infections of cultured cells or embryonated chicken eggs. The noncyto-
pathic nature of cells infected or co-infected with rSeVGP42 leads automatically to stable, persistent infections. The mutation
in rSeVGP42 is not in the protein coding regions of the viral genome, but in the 55-nt-long leader region which controls
antigenome synthesis from genome templates. The SeV leader regions, which are expressed as short RNAs, thus appear to
control the induction of PCD. © 1998 Academic Press
INTRODUCTION
Apoptosis, or programmed cell death (PCD), is a phys-
iological process in which unwanted cells are eliminated
from a multicellular organism (Kerr et al., 1972; Raff et al.,
1993). This process consists of a well defined morpho-
logical sequence of events in which the contents of the
cell are packaged within membranes prior to their bud-
ding from the cell as apoptotic bodies. These bodies are
subsequently eliminated by macrophages, and as the
contents of the apoptotic cells are not liberated into the
extracellular space, this process occurs without the in-
duction of an inflamatory response (Arends and Wyllie,
1991). PCD is now accepted as a critical element in the
repertoire of potential cellular responses to many differ-
ent situations, including virus infection. To promote sur-
vival of the host organism, infected cells may be moti-
vated to commit ‘‘altruistic ’’ suicide. This pathway has
been postulated to be an important host defense mech-
anism, leading to the reduction of the organism’s total
virus burden. As obligate intracellular parasites, many
viruses have therefore evolved strategies for preventing
or delaying PCD (Gillet and Brun, 1996). Some viruses,
for example, encode gene products which directly inhibit
cell death pathways [adenovirus E1B 19K (Rao et al.,
1992; White et al., 1992), baculovirus p35 and OpIAP
(Clem et al., 1991; Birnbaum et al., 1994), cowpox CrmA
(Ray et al., 1992; Kamita et al., 1993), and Epstein–Barr
virus BHRF1 (Gagliardini et al., 1994)], whereas other
viral gene products upregulate the expression of cellular
‘‘anti-death’’ genes [e.g., Epstein–Barr virus LMP (Hen-
derson et al., 1993)]. In addition, a growing number of
viruses are now known to actively induce apoptosis late
in the infection, which may represent an important step
in the spread of the progeny to neighboring cells which
can endocytose the apoptotic bodies (Teodoro and Bran-
ton, 1997).
This paper reports that Sendai virus (SeV), a respi-
ratory pathogen of mice and a model paramyxovirus,
also kills cells in culture by inducing PCD. SeV might
therefore be expected to encode a function(s) which
interferes with this pathway. We have no evidence that
this is so, but we have found a mutant virus (rSeVGP42)
which grows normally but does not kill cells in culture.
This property (PCD2), moreover, is dominant in cells
co-infected with SeVwt and rSeVGP42. rSeVGP42 appears
to have gained a function which prevents PCD induced
by SeVwt. Curiously, the mutation in rSeVGP42 lies not in
the protein coding regions of the viral genome, but in
the 55-nt-long leader region which controls antig-
enome synthesis from genome templates. This region
is expressed as short RNAs, and the work described
here suggests that these RNAs may play a role in
controlling the induction of PCD.
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RESULTS
Organization of paramyxovirus genomes
The linear genomes of nonsegmented negative-strand
([2]) RNA viruses (Rhabdoviridae, Paramyxoviridae, and
Filoviridae) vary from 11 to 19 kb in length and express
from 5 to 10 genes (or transcription units). One feature
Mononegaviruses share, and which distinguishes them
from segmented [2] RNA viruses, is that the 59 end of the
first mRNA is recessed from the 39 end of the [2] ge-
nome template, and this interval is made up by the short
[1] leader (le1) region (Fig.1). The very 39 end of the [2]
genome is, nevertheless, expressed as a short le1
RNA(s) (ca 55 nt for SeV), which terminates near the start
of the first mRNA (reviewed in Banerjee and Barik, 1992;
Lamb and Kolakofsky, 1996). The polymerase that has
made the le1 RNA may then continue on, to sequentially
synthesize the linear array of mRNAs (shown as a single
generic mRNA in Fig. 1). An analogous [2] leader (le2)
RNA is expressed from the 39 end of the antigenome (57
nt for SeV), containing the sequences up to the end of the
L gene (Leppert et al., 1979; Vidal et al., 1989; Chandrika
et al., 1995 ). As there are no other reinitiation sites
downstream of the le2 region on the antigenome, the le2
RNAs are the only subgenomic length transcripts of the
antigenome (Fig. 1).
RNA synthesis from the le1 and le2 regions is thought to
play a central role in controlling antigenome synthesis from
genome templates, and vice-versa (Fig. 1) The le regions
can thus be considered as RNA promoters for genome
replication. The le2 region (or antigenomic) promoter will
also be referred to as PR, and that of the le1 region (or
genomic promoter) as PL, in reference to their representa-
tion in Fig. 1 in the convention used for protein-encoding
DNA. For SeV, the genomic promoter (at PL) includes not
only the le1 sequence up to the start of the N gene (nt56),
but at least part of the adjacent 59 nontranslated region
(Pelet et al., 1996; Tapparel and Roux, 1996). Similarly, the
antigenomic promoter (at PR) includes not only the le2
sequence up to the end of the L gene, but at least part of the
adjacent 39 nontranslated region (Murphy et al., 1998; Tap-
parel and Roux, 1998). We use the term PL (and PR) to refer
to the cis-acting sequences at the 39 end of the genome as
well as their complement at the 59 end of the antigenome
(and vice versa). Similarly, le1 refers to the sequences
present both at the 39 end of the genome and the 59 end of
the antigenome. This is because sequences on both
strands most likely control the rate-determining steps for
genome/antigenome synthesis; i.e., (1) the rate at which the
polymerase starts at the very ends of the templates, and (2)
the rate at which the nascent leader chains are assembled
with N subunits. Failure to assemble the nascent leader
chains results in polymerase termination near the le1/N
and L/le2 junctions, to generate the free le RNAs.
Defective interfering (DI) genomes are deletion mutants
generated by a copy-choice mechanism, in which the viral
replicase (carrying its nascent chain) either jumps forward
on its template, creating an internal deletion (e.g., DI-E307,
Fig. 1), or jumps back on the nascent chain itself, creating
a terminal complementary repeat upon finishing the chain
(e.g., H4, Fig. 1)(Leppert et al., 1977; Perrault, 1981, Lazzarini
et al., 1981; Re, 1990; Engelhorn et al., 1993). These latter
DIs are called ‘‘copybacks,’’ and all natural examples have
replaced their genomic promoters at PL with the anti-
genomic promoter and therefore contain the antigenomic
promoter at both ends (Fig. 1). SeV copyback DI genomes
have a competitive advantage in replication over the non-
defective genome (and over DI-E307), and this has led to
the notion that the antigenomic promoter is more efficient
FIG. 1. The organization of copyback, internal-deletion, and standard
SeV genomes. The nondefective [2] genomes and [1] antigenomes
are shown at the top as nucleocapsids (thick boxes), with their various
regions shaded differently, and whose proportions do not reflect their
true sizes. The numbering convention used starts at the le1 region (the
39 end of the [2] genome or 59 end of the [1] antigenome) and ends
with the le2 region (nt 15,384 for nondefective SeV), consistent with the
direction of gene expression. DI-E307 (shown at the bottom) is derived
from the nondefective genome by a single internal deletion (white
slanted bar), in which nt 607 (in the N gene) is fused to nt 14,197 (in the
L gene). The copyback DI-H4, in contrast, has fused the complement of
nt 15,274–15,384 to nt 14,084, thereby duplicating the 57-nt-long le2
region (and the adjacent 53 nt, shown as L9) as a 110-nt inverted repeat
at the other end. The only difference between rSeVGP42 and SeVwt
(listed as GP42 and SeV), in which the first 42 nt of the wild-type
left-hand promoter PL was replaced with the corresponding sequence
of PR, is highlighted. The directions of RNA synthesis are indicated with
arrows. Leader transcripts are shown as boxes of medium thickness,
shaded according to their origin.
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than the genomic promoter. For example, the amplification
efficiencies of the H4 and E307 DI constructs vary by ca.
20-fold in favor of H4 in the vTF7-3 infected/transfected cell
system (Fuerst et al., 1986). Calain and Roux (1995) exam-
ined the cis-acting sequences responsible for this differ-
ence by progressively swapping the sequences at PL of the
H4 and E307 DI genomes with the alternate le region. They
found that the relative amplification advantage of the copy-
backs was determined primarily by whether the DI ge-
nomes contained the le2 sequences at both ends, inde-
pendent of whether or not they expressed mRNAs.
One of the chimeric DI-E307 derivatives used in this
study was designated E307GP42, as the first 42 nt of the
genomic promoter at PL was replaced with the corre-
sponding sequence of PR (DI-E307GP42 is thus a copy-
back over 42 nt). DI-E307GP42 was of particular interest
because it replicated to almost the same high levels as
DI-H4 (copyback over 110 nt (Calain et al., 1992)),
whereas the expression of its single fusion mRNA was
reduced only slightly (Calain and Roux, 1995). Using a
recombinogenic system for the recovery of infectious
virus from DNA (Schnell et al., 1994), PL of DI-E307GP42
was crossed into the nondefective viral genome, creating
the recombinant rSeVGP42 (Garcin et al., 1995). rSeVGP42
appeared to replicate less well in embryonated chicken
eggs than wild-type virus (SeVwt), but had the remarkable
property of excluding SeVwt in co-infections of eggs, i.e.,
rSeVGP42 had retained the interfering properties of the
defective genome. Interference thus appeared to be due
to the presence of le2 sequences at both PL and PR. The
present study was undertaken to understand the repli-
cative advantage of rSeVGP42 in mixed infections and to
investigate why this highly robust copyback virus has not
been detected in nature.
Replication of rSeVGP42 and SeVwt in cultured cells
To compare the replication of SeVwt and rSeVGP42 in
cell culture, BHK cells were infected with 10 PFU/cell of
SeVwt, allantoic fluid containing an equivalent amount of
rSeVGP42 (Materials and Methods, and see below), or a
mixture of the two stocks. Cytoplasmic extracts were
prepared at 9, 24, and 48 hpi and separated on CsCl
density gradients into fractions containing the viral mR-
NAs or genomes/antigenomes, and the levels of the
various viral RNAs were determined by Northern blotting
and primer extension (Materials and Methods). We found
that genomes accumulated roughly to equivalent levels
in all three infections (Figs. 2 and 3; slightly more ge-
nomes were found when rSeVGP42 is present, presum-
ably because little or no CPE occurs at later times, see
below). This is consistent with the fact that the antig-
enomic promoter at PR (which directs genome synthesis)
has not been altered between SeVwt and rSeVGP42 (Fig.
1). Figure 2 also shows that the shorter (1794 nt) DI-
E307GP42 (used to generate rSeVGP42) is not detected in
the rSeVGP42 infections; hence the properties of this virus
stock cannot be ascribed to contaminating DI genomes.
Antigenomes and mRNAs (Fig 3), on the other hand,
accumulated in lesser amounts in rSeVGP42 compared to
SeVwt-infected cells. This is consistent with the fact that
the promoter at PL (which directs antigenome and mRNA
synthesis from genome templates) differs in these two
viruses. This difference in antigenome levels, however, is
in the direction opposite to that expected (see Discus-
sion). In the mixed virus infection, antigenome levels
remained low similar to those in the rSeVGP42 infections,
whereas N mRNAs accumulated to levels approaching
those of the SeVwt infection. The presence of the co-
infecting rSeVGP42 genome appears to suppress anti-
genome synthesis from the normal (noncopyback) ge-
nome, but has a smaller inhibitory effect on mRNA ac-
cumulation from the SeVwt genome.
The SeVwt used in this study is strain H (SeVH),
whereas rSeVGP42 is derived from the very closely re-
lated SeVZ. SeVH was chosen because its N protein (NH)
is electrophoretically distinguishable from that of strain
Z. The N proteins from both viral genomes can thus be
monitored simultaneously by SDS–PAGE. When equal
amounts of cell extracts prepared at 9, 24, and 48 hpi
were examined by immunoblotting, slightly less NZ than
NH was found intracellularly in their respective infections
FIG. 2. Time course of genome accumulation in infected BHK cells.
BHK cells were infected with 10 PFU/cell of SeVwt (lanes wt), an
equivalent amount of rSeVGP42 (lanes GP42), or both virus stocks (lanes
mix). Cells were harvested at the times postinfection indicated above,
and their cell extracts were separated into pelleted and banded mate-
rial on CsCl density gradients. Equal amounts of the banded material
were examined by Northern blotting for the levels of [2] genomes
using a riboprobe derived from the C-terminal end of the L gene
(Curran et al., 1991). Lane DI shows a parallel infection of BHK cells
with a mixture of SeVwt and DI-E307GP42, to mark the position of this DI
genome on the blot.
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(Fig. 4, top), consistent with the lower N mRNA levels in
the rSeVGP42-infected cells (Fig. 3). Both N proteins were
also present in roughly similar amounts during the mixed
virus infection (lanes mix). Culture supernatants were
harvested at 24 and 48 hpi and their virus particles were
examined. Again, roughly equal amounts of NH and NZ
were found extracellularly in virus particles in their re-
spective infections, as well as in the mixed virus infection
(Fig 4, medium). Genome-specific RT/PCR amplification
showed that both viral genomes were also present
throughout the mixed infection (Fig. 5). We conclude that
SeVwt and rSeVGP42 infections of BHK cells accumulate
roughly similar amounts of viral proteins intracellularly
and liberate similar amounts of virus into the medium.
Further, cells co-infected with both viral genomes also
secreted both viral N proteins into the medium. Only the
intracellular levels of antigenomes and mRNAs appear to
differ significantly in these virus infections.
rSeVGP42 produces noncytopathic persistent
infections
We previously reported that we were unable to accu-
rately titer rSeVGP42, as this virus produced pin-hole
plaques at best, whose titer was at least 2 logs dimin-
ished relative to the amount of viral proteins and ge-
nomes present (Garcin et al., 1995). We therefore nor-
malized the rSeVGP42 and SeVwt infections of cell cul-
tures to the amounts of virus particles (pelletable N
protein and viral genomes) in the allantoic fluid stocks.
We found that cells infected with SeVwt showed clear
cytopathic effects (CPE) by 24 hpi, which then increased
in severity, and the vast majority of the cells had died by
72 hpi (Fig. 6). Cells infected with rSeVGP42, in contrast,
exhibited only mild CPE by 48 hpi, which did not increase
on further incubation. Rather, the CPE was transient and
had disappeared by 72 hpi, and the cultures could then
be passaged with almost the same plating efficiency as
FIG. 3. Time course of genome, antigenome, and mRNA accumulation
in infected BHK cells. BHK cells were infected and their cell extracts
fractionated as for Fig. 2. The levels of genomes (G) and antigenomes (AG)
in the CsCl banded material were determined simultaneously by primer
extension with a mixture of primers (top, A). The 59 end of the antigenome-
specific primer is 126 nt from the 59 end of its template, and that of the
genome-specific primer is 114 nt away from the genome 59 end. A DNA
sequence ladder was run alongside for reference, only one lane of which
is included. The levels of N mRNA in the CsCl pelleted material were also
determined by primer extension (bottom, A). The strongest band repre-
sents nt 56, the first base of the N mRNA. The intensities of the various
bands were determined in a PhosphorImager (Molecular Dynamics), and
the results are plotted in B.
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mock-infected cultures (cf. Fig. 6). Immunoblot analysis
of cytoplasmic extracts of these cultures showed that
they were persistently infected (data not shown). Re-
markably, cells co-infected with equal amounts of SeVwt
and rSeVGP42 behaved similarly to those infected with
rSeVGP42 alone; i.e., CPE was mild and transient, and the
cells could be passaged and were persistently infected
(Fig. 6). The time course of the ability of rSeVGP42 to
prevent CPE of cells infected with SeVwt was examined.
When the copyback virus was added to cells infected
with SeVwt either 75 or 150 min earlier, these infections
behaved similarly to those infected with SeVwt alone, i.e.,
CPE was extensive by 48 hpi and none of the cells
survived (Fig. 6). rSeVGP42 must therefore be present at
the earliest times of infection of cells by SeVwt, to protect
against the CPE of the wild-type virus.
When both viruses are added to cells simultaneously
and these cultures (with minimal CPE) are passaged at
48 or 72 hpi, the persistently infected cells grow a little
more slowly (Fig. 6). This difference in growth rate is lost
by the second passage, and the persistently infected
cells now divide at least as quickly as uninfected cells.
Moreover, they can be passaged at much higher dilu-
tions than control BHK cells. The degree to which a
confluent culture can be divided for passage (its plating
efficiency) varies among different cell lines. The BHK
cells we used were routinely passaged at a dilution of
1:8 and grew to confluence within 3 days. Plating at
higher dilutions (1:12) resulted in slower growth, and at a
dilution of 1:20, these cells did not divide and the culture
could not be continued. Cultured cells are thought to
require a minimal level of stimulation from other cells to
stay alive, which condition the medium with growth fac-
tors. In the absence of a given threshold of growth
stimulation, the (default) PCD pathway is activated (Raff,
1992). The baculovirus p35 anti-apoptotic gene is known
to increase cell proliferation by inhibiting PCD, similar to
the action of oncogenic phorbol esters (reviewed in Mc-
FIG. 5. The relative levels of SeVwt and rSeVGP42 antigenomes in
infected cells. RNA was prepared from the various virus-infected BHK
cells (A and B) (Materials and Methods). Equal amounts of the RNA (1/6
of a 9-cm dish) were amplified by RT-PCR using one leftward primer
common to SeVwt and rSeVGP42, and two rightward primers, one spe-
cific for SeVwt (wt, PCR fragment of 105 nt) and one specific for rSeVGP42
(GP42, PCR fragment of 146 nt)(see C). The plus signs following GP42
and wt in A and B indicate which of these genome-specific rightward
primers were used. The times of harvest postinfection (hpi) are indi-
cated above; lanes V here refers to RT-PCR of the virus stocks used for
these infections. P1 and P3 in B refer to passage 1 and passage 3 of
the persistently co-infected cultures, respectively.
FIG. 4. Time course of N protein accumulation intra- and extracellu-
larly. BHK cells were infected with SeVwt (wt), rSeVGP42 (GP42), or a
mixture of both viruses (mix), and the cells and their supernatants were
harvested at the times postinfection indicated. Cytoplasmic extracts
were prepared from the cells, and equal amounts (1/50 of a Petri dish,
and 1/5 of pelletable material from the medium) were separated by 10%
SDS–PAGE and examined by immunoblotting with a mixture of anti-N
and anti-P (Materials and Methods). The N protein of rSeVGP42 (NZ)
migrates slightly faster than that of SeVwt (NH).
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Conkey et al., 1994). In contrast to uninfected cells, BHK
cells persistently infected with rSeVGP42 could be pas-
saged at a dilution of 1:40 without significant effect on
their plating efficiency. This result is consistent with the
notion that the threshold of growth stimulation below
which the default PCD pathway is activated has been
significantly lowered in these persistently infected cells
(see below).
The relative presence of the co-infecting genomes
was monitored by RT-PCR. Whereas both viral genomes
were present at roughly equal levels at early times, there
appeared to be more rSeVGP42 than SeVwt at 48 hpi (Fig.
5B, lanes 5 and 6). Further, rSeVGP42 clearly predomi-
nated over SeVwt by passage 1 (P1; lanes 7 and 8) and
was the only genome detectable by passage 3 (P3; lanes
9 and 10). Both the rSeVGP42 and mixed virus-infected
cultures remained persistently infected to at least pas-
sage 9 (determined by RT-PCR and immunoblotting (not
shown)). One persistently infected BHK culture has now
been kept continuously for 8 months and contained the
same level of viral macromolecules throughout this time
as those found 48 hpi (not shown). The intracellular
accumulation of viral macromolecules in itself is there-
fore insufficient to induce CPE. Moreover, basically the
same results were obtained with LLC-MK2 (monkey kid-
ney), HeLa, A549, and 293 (human) cell lines; i.e.,
whereas infection with rSeVwt was highly cytopathic,
none of these cells survived subsequent passage, and
the CPE of cells infected with rSeVGP42 was inapparent to
mild, the vast majority of these cells survived (as deter-
mined by staining with vital dyes), and the cells could be
passaged at high plating efficiency. Three conclusions
can be drawn from these experiments: (i) infection of
several cultured cells with rSeVGP42 is relatively noncy-
topathic and leads to long-term persistent infections at
high frequency; (ii) rSeVGP42 somehow prevents or atten-
uates the cytopathic effects of SeVwt in mixed infections,
also leading to persistent infections; and (iii) rSeVGP42
has a replicative advantage over SeVwt in cell culture (as
well as in eggs) and even in the absence of the severe
CPE of SeVwt, which would be expected to limit viral
replication and budding. The nature of this advantage is
discussed below.
SeVwt infection of cultured cells induces programmed
cell death
The ability of co-infecting rSeVGP42 to prevent SeVwt
from killing cells, even though the SeVwt genome ap-
peared to be amplified and expressed without gross
abnormalities in these co-infections, was unexpected.
This led us to examine whether SeVwt kills cells by
inducing PCD. Many viruses are now recognized to kill
cells via this physiological pathway (reviewed in Levine
et al., 1996), in part because they activate the dsRNA-
dependent p68kinase or other components of anti-viral
defense mechanisms, which themselves can induce ap-
optosis (Lee and Estaban, 1994, Lee et al., 1997). Char-
acteristic properties of PCD include the condensation of
chromatin along the inner surface of the nuclear mem-
brane and the degradation of its DNA into a ladder of
nucleosomal length fragments (Wyllie and Morris, 1982;
Lazebnik et al., 1993). SeV is known to induce PCD in
human blood monocytes (Tropea et al., 1995), and we
therefore investigated the effects of SeVwt and rSeVGP42
on the ultrastructure of infected Vero cells by electron
microscopy. As shown in Fig. 7, cells infected with SeVwt
showed the characteristic morphology of cells undergo-
ing PCD, with prominent margination of the chromatin
and a condensed, vacuolated cytoplasm. In contrast,
cells infected with rSeVGP42 contained nuclei which
showed no evidence of chromatin margination. The cy-
toplasms of these cells contained cytoplasmic vesicles
as well as some larger vacuoles which appeared to
contain endocytosed virus particles (Fig. 7). Further,
ethidium bromide-stained gels of various infected cell
nucleoplasmic extracts showed that the characteristic
180- to 200-bp DNA ladder could be detected by 24 hpi in
SeVwt-infected cells and the ladder increased in intensity
at 48 hpi. In contrast, no DNA fragments could be de-
tected in the lower region of the gel in the control mock-
infected cell extracts. Extracts of rSeVGP42-infected cells,
on the other hand, contained as few DNA fragments as
the mock-infected controls (data not shown).
FIG. 6. Cytopathicity of SeVwt and rSeVGP42. Parallel confluent cul-
tures of BHK cells in 9-cm dishes were either mock-infected (ctl) or
infected with 10 PFU/cell (or equivalent amounts) of SeVwt (wt), rSe-
VGP42 (GP42), or both viruses (wt 1 GP42). rSeVGP42 was added to the
mixed infections either together with SeVwt (09), 75 min after SeVwt (759),
or 150 min after SeVwt (1509). Two dishes were trypsinized at the times
indicated, their cells stained with trypan blue, and the average number
of viable cells is shown. The vertical arrow at 48 hpi indicates that
either the entire culture, or 2 3 106 cells at this time, were replated and
followed until 96 hpi.
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The above characteristics of PCD are, however, diffi-
cult to quantify. We therefore examined other properties
that are more indicative of the fraction of the cells un-
dergoing PCD. One method for detecting apoptosis, and
which can distinguish it from necrosis, is based on the
changes which occur in the plasma membrane during
this process of physiological death, so that these cells
can be eliminated by phagocytosis before they can elicit
an inflammatory response. These changes maintain the
integrity of the plasma membrane and dyes like trypan
blue and propidium iodide are excluded. However, there
is a looser packing of the phospholipids in the mem-
brane and the appearance of phophatidylserine in the
outer leaflet, among other changes. This latter property
has been developed by Vermes et al. (1995) into a flow
cytometric assay using annexin V, a Ca21-dependent
phospholipid binding protein. Studies with annexin V
showed that phophatidylserine exposure begins early
after the onset of apoptosis in all cell types, under the
action of a wide variety of initiators of apoptosis. Al-
though this assay has normally been used to measure
apoptosis in cells in suspension, it has recently been
adapted for adherent cells (van Engeland et al., 1996).
Parallel cultures of HeLa cells were infected with 8
PFU/cell of SeVwt, rSeVGP42, or both viruses and exam-
ined by flow cytometry after reaction with annexin V and
propidium iodide staining of DNA as an indicator of
necrosis. As a negative control, mock-infected cells were
examined, and as a positive control, cells were treated
with UV light. As shown in Fig. 8A, 15.7% of the SeVwt-
infected cells were judged to be apoptotic by this test vs
0.6% of the mock-infected control. In contrast, only 2.8%
of the rSeVGP42-infected cells and 3.5% of the mixed
virus-infected cells were found to be apoptotic.
Another early and specific marker of apoptosis is the
caspace-induced conversion of the U1 snRNP 70-kDa
protein, essential for splicing of pre-mRNAs, to its 40-kDa
cleavage product (Casciola-Rosen et al., 1994). The rel-
ative levels of the U1 70- and 40-kDa proteins in extracts
of the various virus-infected and control cell cultures
FIG. 7. Ultrastructure of SeVwtand rSeVGP42-infected cells. A typical example of a Vero cell infected with SeVwt at 48 hpi, showing margination of
the chromatin and condensation and vacuolization of the cytoplasm. A parallel infection of Vero cells with rSeVGP42 at 48 hpi, showing nuclei with
dispersed chromatin, is also shown. Note that the magnification of the SeVwt-infected apoptotic cell is more than twice that of the rSeVGP42-infected
cells, to better show the changes in ultrastructure. Extracellular virus particles are visible at the lower left of this cell.
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were therefore examined by immunoblotting (Materials
and Methods). As shown in Fig. 8B, the vast majority of
the U1 gene product was the 40-kDa form in the UV-
treated cells, whereas only 3% was cleaved in the un-
treated cells. SeVwt infection led to the cleavage of the
majority of these proteins (80–85%) , whereas infection
with rSeVGP42, or both viruses, led to the cleavage of a
much smaller fraction of the protein (16–23%). Infection
with VSV, another mononegavirus known to induce PCD
(Koyama, 1995), also efficiently led to the accumulation of
the 40-kDa product (lane 9, Fig. 8B). Unexpectedly, the
auto-immune patient sera used here were found to also
react with the SeV N protein, and this serves as an
internal control for the general level of virus replication
(i.e., accumulation of viral genomes) in the various infec-
tions. We conclude that SeVwt kills cells in culture, as in
human blood monocytes, by inducing PCD, and that
rSeVGP42 is noncytopathic because it does not induce
PCD. Moreover, in co-infections of rSeVGP42 and SeVwt,
rSeVGP42 appears to prevent SeVwt from inducing PCD.
Mapping the leader region required to induce PCD
Replacement of the terminal 42 nt of the le1 se-
quence normally present at PL with the equivalent le2
sequences (normally present only at PR) leads to a
virus which cannot induce PCD. We therefore investi-
gated the extent of this replacement necessary to
prevent this induction. rSeVGP viruses in which the
terminal 24, 30, 33, and 48 nt of the le1 sequence at PL
FIG. 8. The extent of apoptosis in SeVwt, rSeVGP42, and mixed virus-infected cells. FACS analysis of HeLa cells infected with the various viruses
as indicated, after staining with annexin V and propidium iodide. The upper right quadrant indicates that fraction of the population of cells undergoing
necrosis, and the lower right quadrant indicates that fraction of the population of cells undergoing apoptosis. UV1 and UV2 are cultures irradiated
with 25 and 50 J/m2 of 254-nm light (Materials and Methods). The relative levels of the U1 70- and 40-kDa proteins in HeLa cells infected with the
various viruses as indicated, as well as VSV, were determined by immunoblotting with an autoimmune patient sera directed against the U1 70-kDa
protein (serum B175). The fraction of the total represented by the 40-kDa protein (% cleaved) was determined by densitometry. Lanes 3–5 show the
results of infection with 2 PFU/cell of each virus, lanes 6–8 show the results of infection with 10 PFU/cell, and lane 9 shows the infection with 10
PFU/cell of VSV-Indiana. Only 1/5 as much material was loaded in lane 9.
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were replaced with the equivalent le2 sequences
were also prepared (similarly to rSeVGP42 (Garcin et
al., 1995)), and their ability to kill cells, as well as to
induce PCD, were studied. As shown in Fig. 9A, rSe-
VGP24 and rSeVGP30 were highly cytopathic like SeVwt,
whereas rSeVGP33, rSeVGP42, and rSeVGP48 were in-
FIGURE 9
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creasingly less cytopathic. Similarly, the increasing
replacement of the terminal le1 sequences at PL with
le2 sequences led to a decreasing fraction of infected
cells appearing apoptotic by flow cytometry (Fig. 9B). A
decreasing fraction of their U1 70-kDa protein was
also cleaved (Fig. 9C), even though the viral proteins
had accumulated to wt levels in all the rSeV-infected
cells (Fig. 9C). These results suggest that the second
half of the le sequence at PL are important in modu-
lating PCD.
DISCUSSION
rSeVGP42 grows slightly less well than SeVwt in eggs
(Garcin et al., 1995) or in cultured cells (Figs. 3 and 4).
Nevertheless, when these same cells are co-infected
with both viruses, SeVwt is progressively excluded by
the presence of the copyback nondefective genome.
This exclusion appears to be due to the intracellular
interference of SeVwt genome amplification by that of
rSeVGP42. This phenomenon is not entirely unex-
pected, as rSeVGP42 has in part duplicated the le2
FIG. 9. The effects on apoptosis of replacing increasing amount of le1 sequences at PL with the equivalent le- sequences.(A) Parallel cultures of Hela
cells were infected with 10 PFU/cell of the various rSeV indicated. At 48 hpi, the cultures were trypsinized and passaged with a 1 to 4 dilution. After 48 h
of further culturing, the cells were stained with Giemsa. (B) Parallel cultures of HeLa cells were infected with 10 PFU/cell of the various rSeV indicated in
duplicate, or treated with 9 and 50 J/m2 of 254-nm light (UV1 and UV2). At 48 hpi, the cells were examined by FACS analysis as for Fig. 8, and the average
of the fraction of the cells in the lower right quadrant is shown (the bar indicates the range). M refers to mock-infected cells.(C) The same samples as in
B were analyzed by immunoblotting for the percentage cleavage of the U1 70-kDa protein to its 40-kDa product as for Fig. 8B, except that autoimmune patient
serum K20, which also reacts with the lower host band indicated, and anti-L antibody, which also reacts with the upper host band indicated, was used. A
separate membrane (bottom) was stained with a mixture of anti-L, anti-P, and anti-N sera (Materials and Methods).
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sequences at PL, like copyback DI genomes. In the
case of rSeVGP42 and SeVwt, the intracellular interfer-
ence is unlikely to be due to a stronger (antigenomic)
promoter now being present at PL, as rSeVGP42-in-
fected cells actually accumulate less antigenomes rel-
ative to genomes (Fig. 3). The interference with SeVwt
genome amplification may act via the promoter-spe-
cific inhibitory effects of the viral C proteins, which are
mostly nonstructural proteins expressed from the P
gene. C protein expression strongly inhibits the am-
plification of DI-E307 (in transfected cells) under con-
ditions where there is little or no effect on that of
copybacks DI-H4 and DI-E307GP42. Further, whereas C
expression prevents the recovery of SeVwt from DNA in
this transfected cell system, it does not prevent the
recovery of the copy-back nondefective rSeVGP42 from
DNA (Cadd et al., 1996). The copyback arrangement of
promoter ends (Fig. 1) is apparently resistant to the C
protein inhibition of RNA synthesis, because the C-
sensitive sequences of PL have been replaced by the
equivalent but relatively insensitive sequences of PR.
We also note that the replicative advantage of rSe-
VGP42 over SeVwt is one that is limited to co-infections,
where both genomes normally express C proteins, but
rSeVGP42 is less sensitive to their inhibitory effects.
This advantage is presumably limited in the natural
environment where direct competition of two similar
viruses in animals is rare. A virus with a larger burst
might be more successful on the whole, and this may
account for why copyback nondefective viruses have
not been found in nature.
We have found that SeV kills cells in culture by inducing
PCD, similar to its effect on human peripheral blood mono-
cytes (Tropea et al., 1995). The major finding of this study,
however, is that rSeVGP42 is unable to induce PCD and that
rSeVGP42 is also able to prevent SeVwt from inducing this
cellular response in co-infected cells. Further, the increas-
ing replacement of the terminal le1 sequences at PL with
le2 sequences led to a decreasing fraction of infected cells
appearing apoptotic by flow cytometry. A decreasing frac-
tion of their U1 70-kDa protein was also cleaved (Fig. 9),
even though the viral proteins had accumulated to wt levels
in all the rSeV-infected cells. The dominant nature of rSe-
VGP42 in preventing PCD induced from infection with SeVwt
(and possibly also from insufficient growth stimulation at
low plating densities) would normally classify this virus as
a gain-of-function mutant, i.e., rSeVGP42 appears to have
acquired the capacity to prevent PCD. While this is true in
one respect, it is also misleading, as it surmises an evolu-
tionary advantage of the mutated virus, for which there is no
evidence. The acquired ability to prevent PCD is also un-
usual, given that the protein coding regions of the viral
genome are unchanged. We found that the different se-
quences at PL between rSeVGP42 and SeVwt result in rela-
tively modest differences in the amounts of viral mRNAs
during the course of the infection, and even smaller differ-
ences in the amounts of viral proteins and genomes, espe-
cially in the co-infections. It is therefore unlikely that the
acquired capacity to inhibit PCD is due to the relative
amounts of these macromolecules, although this cannot at
present be excluded. It appears more likely that the gain of
function results from the le sequences themselves, which
are expressed as short le RNAs from PL and PR. It has been
known for some time that the presence of copyback DI-H4
genomes in SeV stocks also prevents the CPE of SeVwt and
leads to persistent infections. This is so even though the
amounts of viral proteins and genomes intracellularly are
similarly unchanged or in fact often augmented (Roux and
Holland, 1979; Roux and Waldvogel, 1981). It thus seems
likely that DI-H4 and rSeVGP42 prevent PCD induced by
SeVwt similarly.
The common characteristic of the DI-H4/SeVwt and
rSeVGP42/SeVwt mixed infections is the copyback ar-
rangement of promoters on the co-infecting genome,
such that le2 RNAs (or RNAs with mostly le2 se-
quences) are now expressed from PL as well as PR
(Fig. 1). This greatly decreases the ratio of le1/le2
RNAs. The relative absence of le1 RNAs in these
mixed infections could conceivably account for why
the copyback genome can prevent PCD. For the
closely related rhabdovirus VSV whose infection of
HeLa cells also induces PCD (Koyama, 1995), the
analogous le1 RNA is known to interact with the cel-
lular La protein and to enter the nucleus (Kurilla and
Keene, 1983). Here, le1 RNA is thought to participate
in the shut-off of host RNA and DNA synthesis follow-
ing infection (Weck et al., 1979). Infection with VSV
copyback DI particles (which also produce only le2
RNAs), on the other hand, does not shut off the host
cell (Weck and Wagner, 1979). Furthermore, purified
le1 RNA (but not le2 RNA) can partially inhibit RNA
synthesis when added to mammalian cell extracts
(McGowan et al., 1982; see Keene, 1985, for review).
The earliest known effect of the VSV le1 RNA on
cellular metabolism is the inhibition of U1 snRNP mat-
uration, which occurs 15–30 min postinfection (Crone
and Keene, 1989). We have found that VSV infection
also induces the cleavage of the U1 70-kDa protein to
its 40-kDa product, an early marker for PCD (Fig. 8).
Remarkably, this inhibition by VSV occurs even when
there are as few as 100 le1 RNAs/cell, consistent with
the notion that recognition of the VSV le1 RNA is the
primary step leading to the shut-off of host macromo-
lecular synthesis, and to PCD. The induction of PCD by
SeVwt also appears to be a very early event in the
infection (Fig. 6). It will be of interest to determine
whether the paramyxovirus le RNAs also induce the
cleavage of the U1 70-kDa protein when introduced
into cells by means other than SeV infection and to
identify the host proteins with which they interact.
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MATERIALS AND METHODS
Virus levels
Virus levels were determined by:
(1) Pelleting the virus in 1 ml allantoic fluid through
500 ml of 25% glycerol in TNE, at 12,000 rpm for 30 min in
an Eppendorf centrifuge. The pellet was dissolved in
sample buffer, separated by 10% SDS–PAGE, and the gel
stained with Coomassie brillant blue.
(2) By infecting BHK cells with 1/10 dilution of the
different stocks. At various times postinfection, cells
were harvested, lysed with 20 mM Tris–Cl, pH 7.4, 150
mM NaCl, 2 mM EDTA (TNE), plus 0.5% NP-40; and the
cytoplasmic extracts were centrifuged on 20–40% (w/w)
CsCl density gradients to purify the nucleocapsids,
which band at 1.31 g/ml, and the mRNAs which pellet.
The viral RNAs were examined as described below.
(3) Plaque titration on LLC-MK2 cells covered with
0.3% agarose overlay containing 1.2 mg/ml acetyl-trypsin,
for 3–4 days at 33°C.
Primer extension and RT-PCR
RNA from viral nucleocapsids, or mRNA pellets, purified
on CsCl density gradients (from 1/4 of a 9-cm-diameter petri
dish) was used for primer extension and RT-PCR with the
following primers: NP126, 59-126CGGCCATCGTGAACTTT-
GGC107-39, (genomic polarity); le21, 59-21GTATGGAATATATA-
ATGAAG40-39, (antigenomic polarity); tr-15, 59-ATTGGATC-
CGAATGCTACCAGACAAGAGTTTAAGAGATATGTATC-39,
the sequence in italics is a T7 promoter and that in boldface
type is nucleotides 15,384–15,356 (antigenomic polarity);
L15,270, 59-15,270GAAGCTCCGCGGTACC15,285-39 (anti-
genomic polarity).
Reverse transcription reactions were carried out with
the M-MLV enzyme, as described by Gibco/BRL, using
200,000 cpm of 59 32P-oligonucleotides purified by PAGE.
The products of the reaction were separated on 8%
sequencing gels.
Nonradioactive reverse transcription reactions were
carried out as described above with 10 pmol of cold
primers. One-tenth of the reaction was then used directly
for DNA amplification with 1 U Taq DNA polymerase in
50-ml reactions. After 20 cycles (denaturation 30 s at
90°C; annealing 30 s at 50°C; elongation 20 s at 72°C),
the products were separated directly on a 10% polyacryl-
amide gel and visualized with ethidium bromide.
Virus infection and induction of apoptosis
in cell culture
HeLa cells were trypsinized and passaged one to two in
MEM containing 5% heat-inactivated fetal calf serum the
day before. Control apoptosis was induced by irradiation
with 9 to 50 J/m2 of 254-nm light, followed by incubation at
33°C in MEM containing 5% FCS. HeLa cells were also
infected with the indicated PFU/ml of the various virus
stocks for 1 h in 2 ml of medium without FCS, followed by
incubation at 33°C in medium containing 5% FCS. A mock-
infected control was treated identically.
Gel electrophoresis and immunoblotting
HeLa cells (in a 9-cm petri dish) were scraped into
their medium, centrifuged at 500g for 5 min, washed
once in cold PBS, and then lysed in 150-ml buffer con-
taining 0.5% Nonidet P40, 20 mM Tris–Cl, pH 7.4, 150 mM
NaCl, 1 mM EDTA, and a cocktail of protease inhibitors
(pepstatin A, leupeptin, antipain, chymostatin, and
PMSF). Fifty microliters (plus 20 ml of protein loading
buffer) was used for protein analysis, the rest for RNA
extraction. Five microliters of each sample was electro-
phoresed on 10% SDS–polyacrylamide gels and trans-
ferred onto polyvinylidene fluoride membranes. Mem-
branes were reacted with monoclonal antibodies to var-
ious viral proteins, anti-L, anti-P (1–180), and anti-N (N/
877) (Curran et al., 1991), and with auto-immune patient
sera directed against the U1 70-kDa protein and its
cleavage product U1 40 kDa (sera B-175 and K-20, from
Dr. W. J. van Venrooij, Amsterdam (van Venrooij et al.,
1990)). Antibody reaction was detected by enhanced
chemiluminescence (ECL; Amersham).
Measurement of phosphatidylserine exposure
by annexin-V fluorescence
At 48 h postinfection, medium from 9-cm petri dishes
containing adherent HeLa cells (6 3 106 cells) was re-
moved, a quick rinse was performed with 1 ml of 0.05%
trypsin, and 1 ml of 0.05% trypsin was added for 2–3 min.
Once the cells had lifted off, 10 ml of complete medium
containing 10% fetal bovine serum was added, and the cell
suspension was transferred to a 13-ml centrifuge tube and
centrifuged at 500g for 5 min. The supernatant was de-
canted and cells gently resuspended in 10 ml of MEM
containing 10% FCS and centrifuged again as above. Cells
were washed twice with cold PBS and then resuspended in
500 ml of annexin V binding buffer (10 mM Hepes/NaOH,
pH 7.4, 140 mM NaCl, 5 mM CaCl2); 100 ml of this suspen-
sion was used for annexin V staining by adding 2 ml an-
nexin-V-fluos reagent (Boerhinger) and 2 ml of a 50 mg/ml
propidium iodide solution for 10–15 min prior to flow cytom-
etry analysis. For excitation, 488 nm light was used; a
515-nm bandpass filter was used for fluorescein detection
and a filter . 560 nm for PI detection.
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